Related Experiment Video
Updated: Jul 12, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Simeprevir restores the anti-Staphylococcus activity of polymyxins
Yuan Wu1, Pingyun Wu1, Ruolan Wu1
1Department of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, China.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) infection poses a severe threat to global public health due to its high mortality. Currently, polymyxins are mainly used for the treatment of Gram-negative bacterial-related infection, while exhibiting limited antibacterial activities against Staphylococcus aureus (S. aureus). However, the combination of antibiotics with antibiotic adjuvants is a feasible strategy for the hard-treated infection and toxicity reducing. We will investigate the antibacterial activity of simeprevir (SIM), which treated for genotype 1 and 4 chronic hepatitis C, combined with polymyxins against MRSA through high-throughput screening technology. In our study, the synergistic antibacterial effect of SIM and polymyxins against S. aureus in vitro was found by checkerboard assay and time-growth curve. The cytotoxicity of SIM combined with polymyxin B sulfate [PB(S)] or polymyxin E (PE) in vitro was evaluated using CCK-8, human RBC hemolysis and scratch assays. In addition, we investigated the eradication of biofilm formation of S. aureus by biofilm inhibition assay and the killing of persister cells. Moreover, we evaluated the therapeutic effect and in vivo toxicity of the combination against MRSA in murine subcutaneous abscess model. Furthermore, it was preliminarily found that SIM significantly enhanced the destruction of MRSA membrane by SYTOX Green and DISC3(5) probes. In summary, these results reveal that the therapy of SIM combined with polymyxins (especially PE) is promising for the treatment of MRSA infection.
Insights
Simeprevir combined with polymyxins shows synergistic antibacterial effects against methicillin-resistant Staphylococcus aureus (MRSA). This combination therapy is promising for treating MRSA infections with reduced toxicity.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant global health challenge due to its high mortality.
- Polymyxins are primarily used for Gram-negative infections and have limited activity against S. aureus.
- Combining antibiotics with adjuvants offers a strategy to combat difficult-to-treat infections and reduce toxicity.
Purpose of the Study:
- To investigate the antibacterial activity of simeprevir (SIM) in combination with polymyxins against MRSA.
- To evaluate the synergistic effects, cytotoxicity, and therapeutic potential of this combination.
- To explore the mechanism of action, including membrane disruption.
Main Methods:
- High-throughput screening and checkerboard assays were employed to assess synergistic antibacterial effects.
- Time-growth curves, CCK-8 assays, and hemolysis assays evaluated antibacterial activity and cytotoxicity.
- Biofilm inhibition assays, persister cell killing assays, and a murine subcutaneous abscess model were used for further evaluation.
- Membrane integrity was assessed using SYTOX Green and DISC3(5) probes.
Main Results:
- A synergistic antibacterial effect of SIM with polymyxins against S. aureus was confirmed in vitro.
- The combination demonstrated efficacy in eradicating biofilms and killing persister cells.
- In vivo studies in a murine model showed therapeutic potential with acceptable toxicity.
- SIM was found to enhance the membrane-disrupting activity of polymyxins against MRSA.
Conclusions:
- Simeprevir in combination with polymyxins, particularly polymyxin E (PE), exhibits promising therapeutic potential against MRSA infections.
- This combination strategy may offer a viable treatment option for challenging MRSA infections.
- The findings highlight a potential new approach to combatting antibiotic-resistant bacteria.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing

